Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia
about
Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acidEvaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guidelineMolecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein FPhage-displayed recombinant single-chain antibody fragments with high affinity for cholesteryl ester transfer protein (CETP): cDNA cloning, characterization and CETP quantification.Treatment options for hypertriglyceridemia: from risk reduction to pancreatitis.Effects of low-fat diet, calorie restriction, and running on lipoprotein subfraction concentrations in moderately overweight men.Treatment of Dyslipidemias to Prevent Cardiovascular Disease in Patients with Type 2 Diabetes.Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities.Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic miceEffects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women.Genetic polymorphisms and activity of cholesterol ester transfer protein (CETP): should we be measuring them?Lipid regulation in lipodystrophy versus the obesity-associated metabolic syndrome: the dissociation of HDL-C and triglyceridesEffects of dietary cholesterol and fat saturation on plasma lipoproteins in an ethnically diverse population of healthy young men.Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice.Lipid transfer inhibitor protein (apolipoprotein F) concentration in normolipidemic and hyperlipidemic subjects.Effect of alcohol on lipids and lipoproteins in relation to atherosclerosis.Conversion of lipid transfer inhibitor protein (apolipoprotein F) to its active form depends on LDL composition.Increased production rates of LDL are common in individuals with low plasma levels of HDL cholesterol, independent of plasma triglyceride concentrationsPlasma triglyceride and high density lipoprotein cholesterol are poor surrogate markers of pro-atherogenic chylomicron remnant homeostasis in subjects with the metabolic syndrome.Comparison of the effects of fibrates versus statins on plasma lipoprotein(a) concentrations: a systematic review and meta-analysis of head-to-head randomized controlled trials.Postprandial hyperglycaemia and vascular damage--the benefits of acarbose.Control of cholesteryl ester transfer protein activity by sequestration of lipid transfer inhibitor protein in an inactive complexThe dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic miceApolipoprotein CI is a physiological regulator of cholesteryl ester transfer protein activity in human plasma but not in rabbit plasma.Profound induction of hepatic cholesteryl ester transfer protein transgene expression in apolipoprotein E and low density lipoprotein receptor gene knockout mice. A novel mechanism signals changes in plasma cholesterol levelsCiprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver.Postprandial lipid metabolism in relation to coronary heart disease.Apolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice.Rates of cholesterol esterification and esterified cholesterol net mass transfer between high-density lipoproteins and apolipoprotein B-containing lipoproteins in Type 1 diabetes.Increased serum cholesteryl ester transfer protein in obese children.Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader assay.The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects.Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG: effects of bezafibrate therapy.Elevated cholesteryl ester transfer protein (CETP) activity, a major determinant of the atherogenic dyslipidemia, and atherosclerotic cardiovascular disease in South Asians.Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study.Lipoprotein composition influences cholesteryl ester transfer in alcohol abusers.Relationship between cholesteryl ester transfer protein and LDL heterogeneity in familial hypercholesterolemia.Insulin decreases plasma cholesteryl ester transfer but not cholesterol esterification in healthy subjects as well as in normotriglyceridaemic patients with type 2 diabetes.Fasting plasma triacylglycerol concentrations predict adverse changes in lipoprotein metabolism after a normal meal.Effects of diacylglycerol oil on adiposity in obese children: initial communication.
P2860
Q24536167-7DA9435B-89D1-447D-92E1-69A3E2EF7265Q24608464-409DAB3C-A513-4509-9DDD-62E777909342Q28626790-4D681137-FF13-4E78-88D6-4BBFD29E4A95Q33201460-52F16F40-ADF9-4170-B73A-2C1FF6188BCDQ33639909-9A01852F-84F1-4C86-9DB2-771E417F9734Q33687740-60A41304-7AFB-4F61-BDC7-468FE8FA5EB4Q33887783-5EEE6F29-B343-4FDB-ADA9-DE87EC6C5F93Q33889332-3A600018-16DA-4962-B60C-23EEA10CDAA4Q33900976-C8E70AC5-EBFE-4B87-83EE-C9172034A69DQ33993240-E3006FE5-5C01-455B-9051-23CC5CFC047EQ34120028-D99E8AA3-5DF0-42AA-B73C-C86FD36F8EABQ34131027-71FC283D-3B69-4D7B-9CE1-56BBC8D314F5Q34200922-20B2AD2D-12F2-410C-A298-168A2A75FF49Q34207487-33339D44-268F-4354-ADFD-EB9B74D94A45Q34694879-741A829D-A4DD-47AD-AFDA-D146FEE58E74Q34743688-E0706F40-A5F2-4AD6-B3F2-4F14E2A627A3Q35561984-91123410-70B6-4F4E-B827-2CAE79F5315DQ35751599-A305894E-0049-4080-AA8B-FA951BBA8185Q36149080-3DC0A420-10CA-43AB-AC89-29CDD66F6EE5Q36268257-5B5496FA-F1AD-4138-B5F1-E065E552058CQ36632034-9F93BD78-9187-4DC4-A2AF-D90B23C37DEBQ36727392-6A693C0F-DB37-4256-B8DF-A109DF99CE99Q37230691-0CCE50C5-9141-4DEA-8943-6ECC6E1357DAQ37299858-71477B48-7EAA-4E55-9A63-2402D65461BCQ37351233-220B5574-8348-4241-A8A8-C2B31BB214B9Q37444625-45EE6C86-3B39-42F1-B1E3-C92CE071E66BQ41571799-667037A1-77C2-4317-8C30-0491035E9CD6Q41825540-D7B0860B-0CAF-409B-BA0E-0D1DA17B3D32Q44004502-E206424B-9FCB-45EF-B54E-C950516971A1Q44021593-E7E6387C-59A3-4A2A-9832-0CCB6427BE55Q44046083-7194386D-1725-4991-90D4-479DB7C6B668Q44122859-285EB1FB-4D14-4269-AD80-00A9B466177BQ44445906-007896B3-282F-445C-B4EE-2F904FD9EFCEQ44873060-EA904F5E-C15F-4ED1-8A5F-737720FEB93CQ46622451-4ED163FC-276C-4129-8B52-7C6C670F5548Q47793880-95E7756C-4BE3-4C5F-B340-568ED96A5384Q47936739-F675CE54-A479-4C50-8ED4-0081C05E5980Q51561534-5EFF580C-8850-4799-A262-316B241FCA5CQ51594895-BD063742-023F-495A-81B9-635528D98F09Q51792473-88D69621-C2C7-4F24-8272-C67E1F07CAE0
P2860
Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia
description
1991 nî lūn-bûn
@nan
1991 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
name
Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia
@ast
Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia
@en
Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia
@nl
type
label
Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia
@ast
Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia
@en
Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia
@nl
prefLabel
Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia
@ast
Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia
@en
Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia
@nl
P2093
P2860
P356
P1476
Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia
@en
P2093
P2860
P304
P356
10.1172/JCI115535
P407
P577
1991-12-01T00:00:00Z